Internal Server Error

AirXpanders - About the company

AirXpanders is a public company based in Mountain View (United States), founded in 2006. It operates as a Tissue exapnder for post mastectomy reconstructive surgery. AirXpanders has raised an undisclosed amount in funding from investors like Western Technology Investment, Heron Capital and Prolog Ventures. The company has 37 active competitors, including 10 funded and 7 that have exited. Its top competitors include companies like Establishment Labs, GC Aesthetics and Sientra.

Company Details

AirXpanders is developing technology for tissue expansion after reconstructive surgery with the first emphasis in breast reconstruction. AirXpanders has developed the AeroForm tissue expander, a patient controlled breast tissue expander. The AeroForm patient controlled tissue expander includes a small handheld wireless controller that administers small amounts of CO2 into the device to stretch the skin to accommodate a permanent breast implant.
Social
X
Key Metrics
Founded Year
2006
Location
Mountain View, United States
Stage
Public
Latest Funding Round
Ranked
Annual Revenue
$1M - $10M as on Dec 31, 2018
Employee Count
10 - 49 as on Mar 01, 2026
Similar Companies
Exit Details
Public

AirXpanders's IPO details

AirXpanders got listed on Jul 20, 2006.
Click here to take a look at AirXpanders's IPO in detail
Sign up to download AirXpanders' company profile

AirXpanders's funding and investors

AirXpanders has raised funding over 12 rounds. Its first funding round was on Mar 2008. Its latest funding round was a Post IPO round on Sep 11, 2018 for $*****. 1 investor participated in its latest round. AirXpanders has 10 institutional investors.

Here is the list of recent funding rounds of AirXpanders:lockFilter this list
Date of Funding
Funding Amount
Round Name
Post-Money Valuation
Revenue Multiple
Lead Investors
Other Investors
Sep 11, 2018
7767520
Post IPO
4354789
2824052
5250768
1419512
Aug 2017
1654787
Conventional Debt
8175065
5454552
9647681
1858359
Feb 24, 2017
6257130
Post IPO
1173471
1390192
5892466
6274670
lockAccess funding benchmarks and valuations. Sign up today!

AirXpanders' founders and board of directors

Founder? Claim Profile

AirXpanders' employee count trend

AirXpanders has 10 - 49 employees as of Mar 26. Here is AirXpanders's employee count trend over the years:
Employee count trend for AirXpanders
lockUncover AirXpanders' growth story! Sign up today!
chrome_extension_cta_illustration
Access Tracxn on any website
Our Google Chrome extension lets you view company details while browsing their websites
Install Tracxn Extension

AirXpanders's Competitors and alternates

Top competitors of AirXpanders include Establishment Labs, GC Aesthetics and Sientra. Here is the list of Top 10 competitors of AirXpanders, ranked by Tracxn score:
Rank
Company Details
Short Description
Total Funding
Investors
Tracxn Score
1st
Logo for Establishment Labs
Establishment Labs
2010, Alajuela (Costa Rica), Public
Developer of silicone-filled breast and body shaping implants
$121M
70/100
2nd
Logo for GC Aesthetics
GC Aesthetics
2007, Dublin (Ireland), Series E
Manufacturer of silicone breast implants for aesthetic and reconstructive surgery
$233M
56/100
3rd
Logo for Sientra
Sientra
2007, Santa Barbara (United States), Public
Products for plastic surgery/ aesthetics
$150M
53/100
4th
Logo for Healshape
Healshape
2020, Villeurbanne (France), Series A
Developer of products for breast reconstruction and augmentation
$12.8M
51/100
5th
Logo for Lattice Medical
Lattice Medical
2017, Loos (France), Series B
Provider of 3D-printed technology for soft tissue reconstruction
$63.4M
49/100
6th
Logo for BellaSeno
BellaSeno
2015, Leipzig (Germany), Unfunded
Developer of breast implants
-
-
43/100
7th
Logo for BioAesthetics
BioAesthetics
2015, New Orleans (United States), Series A
Developer of a tissue-engineered nipple-areolar complex
$7.4M
42/100
8th
Logo for AirXpanders
AirXpanders
2006, Mountain View (United States), Public
Tissue exapnder for post mastectomy reconstructive surgery
-
41/100
9th
Logo for Tensive
Tensive
2012, Milano (Italy), Series A
Prostheses for a natural breast reconstruction
$16.7M
41/100
10th
Logo for Ideal Implant
Ideal Implant
2006, Dallas (United States), Acquired
Medical device and biologics company innovating tissue and cell-based technologies
$17M
41/100
lockGet insights and benchmarks for competitors of 2M+ companies! Sign up today!
Looking for more details on AirXpanders's competitors? Click here to see the top ones

AirXpanders's Investments and acquisitions

AirXpanders has made no investments or acquisitions yet.

Reports related to AirXpanders

Here is the latest report on AirXpanders's sector:

News related to AirXpanders

lockFilter this list
lockGet curated news about company updates, funding rounds, M&A deals and others. Sign up today!

FAQs about AirXpanders

Explore our recently published companies
Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford